IBDEI0N2 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10371,1,3,0)
 ;;=3^G0108
 ;;^UTILITY(U,$J,358.3,10372,0)
 ;;=98961^^40^440^4^^^^1
 ;;^UTILITY(U,$J,358.3,10372,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10372,1,2,0)
 ;;=2^SELF-MGMT EDUC & TRAIN 2-4 PTS
 ;;^UTILITY(U,$J,358.3,10372,1,3,0)
 ;;=3^98961
 ;;^UTILITY(U,$J,358.3,10373,0)
 ;;=98962^^40^440^5^^^^1
 ;;^UTILITY(U,$J,358.3,10373,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10373,1,2,0)
 ;;=2^SELF-MGMT EDUC & TRAIN 5-8 PTS
 ;;^UTILITY(U,$J,358.3,10373,1,3,0)
 ;;=3^98962
 ;;^UTILITY(U,$J,358.3,10374,0)
 ;;=90707^^40^441^21^^^^1
 ;;^UTILITY(U,$J,358.3,10374,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10374,1,2,0)
 ;;=2^MMR VACCINE
 ;;^UTILITY(U,$J,358.3,10374,1,3,0)
 ;;=3^90707
 ;;^UTILITY(U,$J,358.3,10375,0)
 ;;=90714^^40^441^25^^^^1
 ;;^UTILITY(U,$J,358.3,10375,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10375,1,2,0)
 ;;=2^TD VACCINE
 ;;^UTILITY(U,$J,358.3,10375,1,3,0)
 ;;=3^90714
 ;;^UTILITY(U,$J,358.3,10376,0)
 ;;=90732^^40^441^22^^^^1
 ;;^UTILITY(U,$J,358.3,10376,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10376,1,2,0)
 ;;=2^PNEUMOCOCCAL VACCINE 23 VALENT
 ;;^UTILITY(U,$J,358.3,10376,1,3,0)
 ;;=3^90732
 ;;^UTILITY(U,$J,358.3,10377,0)
 ;;=90662^^40^441^5^^^^1
 ;;^UTILITY(U,$J,358.3,10377,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10377,1,2,0)
 ;;=2^FLU VACC HIGH DOSE SYR (FLUZONE)
 ;;^UTILITY(U,$J,358.3,10377,1,3,0)
 ;;=3^90662
 ;;^UTILITY(U,$J,358.3,10378,0)
 ;;=90736^^40^441^29^^^^1
 ;;^UTILITY(U,$J,358.3,10378,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10378,1,2,0)
 ;;=2^ZOSTER (SHINGLES) VACCINE
 ;;^UTILITY(U,$J,358.3,10378,1,3,0)
 ;;=3^90736
 ;;^UTILITY(U,$J,358.3,10379,0)
 ;;=90670^^40^441^24^^^^1
 ;;^UTILITY(U,$J,358.3,10379,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10379,1,2,0)
 ;;=2^PREVNAR 13
 ;;^UTILITY(U,$J,358.3,10379,1,3,0)
 ;;=3^90670
 ;;^UTILITY(U,$J,358.3,10380,0)
 ;;=90686^^40^441^8^^^^1
 ;;^UTILITY(U,$J,358.3,10380,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10380,1,2,0)
 ;;=2^FLU VACC SGLE DOSE SYR (FLUARIX)
 ;;^UTILITY(U,$J,358.3,10380,1,3,0)
 ;;=3^90686
 ;;^UTILITY(U,$J,358.3,10381,0)
 ;;=90688^^40^441^6^^^^1
 ;;^UTILITY(U,$J,358.3,10381,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10381,1,2,0)
 ;;=2^FLU VACC MULT DOSE SYN (AFLURIA)
 ;;^UTILITY(U,$J,358.3,10381,1,3,0)
 ;;=3^90688
 ;;^UTILITY(U,$J,358.3,10382,0)
 ;;=90723^^40^441^1^^^^1
 ;;^UTILITY(U,$J,358.3,10382,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10382,1,2,0)
 ;;=2^DTAP-HEP B-IPV VACCINE IM
 ;;^UTILITY(U,$J,358.3,10382,1,3,0)
 ;;=3^90723
 ;;^UTILITY(U,$J,358.3,10383,0)
 ;;=90698^^40^441^2^^^^1
 ;;^UTILITY(U,$J,358.3,10383,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10383,1,2,0)
 ;;=2^DTAP-HIB-IP VACCINE IM
 ;;^UTILITY(U,$J,358.3,10383,1,3,0)
 ;;=3^90698
 ;;^UTILITY(U,$J,358.3,10384,0)
 ;;=90697^^40^441^3^^^^1
 ;;^UTILITY(U,$J,358.3,10384,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10384,1,2,0)
 ;;=2^DTAP-IPV-HIB-HEPB VACCINE IM
 ;;^UTILITY(U,$J,358.3,10384,1,3,0)
 ;;=3^90697
 ;;^UTILITY(U,$J,358.3,10385,0)
 ;;=90749^^40^441^4^^^^1
 ;;^UTILITY(U,$J,358.3,10385,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10385,1,2,0)
 ;;=2^DTP VACCINE IM
 ;;^UTILITY(U,$J,358.3,10385,1,3,0)
 ;;=3^90749
 ;;^UTILITY(U,$J,358.3,10386,0)
 ;;=90672^^40^441^9^^^^1
 ;;^UTILITY(U,$J,358.3,10386,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10386,1,2,0)
 ;;=2^FLU VACCINE INTRANASAL,QUADRIVALENT,LIVE
